Radbin Taraneh, Kamali Alireza, Yazdi Bijan, Pazouki Shirin, Hadi Hoseinali, Rakei Siamak
Department of Anesthesiology and Critical Care, Arak University of Medical Sciences, Arak, Iran.
Department of Orthopedics, Arak University of Medical Sciences, Arak, Iran.
J Family Med Prim Care. 2021 Feb;10(2):832-837. doi: 10.4103/jfmpc.jfmpc_1506_20. Epub 2021 Feb 27.
One of the most complex medical problems is pain, that due to inappropriate management of patients after surgery could cause various side effects on the psychological, physiological, and metabolic state of the patients. The natural duration of analgesia can be increased by adding new efficient adjuvant. The present study is mainly aimed to investigate the differences between the epidural dexmedetomidine and ketamine effectiveness when administered as an adjuvant to epidural 0.25% bupivacaine for improving the postoperative analgesia duration.
In the present double-blind clinical study, 105 patients of the age range of 40-85 years were selected for elective femoral surgery and then was divided into three of ketamine, dexmedetomidine, and control randomly. The scores of postoperative pain were evaluated in accordance with the visual Analogue Scale (VAS) criteria and the duration of analgesia and the amount of analgesics consumption were recorded.
The mean pain VAS score during the first day after the surgery and recovery of patients in the dexmedetomidine group was significantly lower in comparison with two other groups ( = 0.01). However, no significant difference was found in the mean VAS score of Paine during 12 and 24 hours after the operation ( ≥ 0.05). Comparisons among these groups demonstrated that the mean on opioid administration during the operation and 24 hours after that was significantly higher in both groups of ketamine and control in comparison with the dexmedetomidine group ( = 0.001 and = 0.01). Besides, analgesia duration among patients belonged to the dexmedetomidine group was notably lower in comparison with two other groups ( = 0.001).
In epidural anesthesia cases adding ketamine and dexmedetomidine as adjuvants to the solution of bupivacaine 0.25%, could increase the duration of analgesia and reduce the consumption of analgesics, which is more in the dexmedetomidine group when compared with ketamine.
疼痛是最复杂的医学问题之一,术后患者管理不当会对其心理、生理和代谢状态产生各种副作用。添加新型有效佐剂可延长自然镇痛时间。本研究主要旨在探讨硬膜外给予右美托咪定和氯胺酮作为0.25%布比卡因硬膜外麻醉佐剂时,在改善术后镇痛持续时间方面的效果差异。
在本双盲临床研究中,选取105例年龄在40 - 85岁的患者进行择期股骨手术,然后随机分为氯胺酮组、右美托咪定组和对照组。根据视觉模拟评分法(VAS)标准评估术后疼痛评分,并记录镇痛持续时间和镇痛药消耗量。
与其他两组相比,右美托咪定组患者术后第一天及恢复期间的平均疼痛VAS评分显著更低(P = 0.01)。然而,术后12小时和24小时疼痛的平均VAS评分在各组间无显著差异(P≥0.05)。这些组间比较表明,氯胺酮组和对照组在手术期间及术后24小时的平均阿片类药物使用量均显著高于右美托咪定组(P = 0.001和P = 0.01)。此外,右美托咪定组患者的镇痛持续时间明显低于其他两组(P = 0.001)。
在硬膜外麻醉病例中,向0.25%布比卡因溶液中添加氯胺酮和右美托咪定作为佐剂,可延长镇痛持续时间并减少镇痛药消耗,与氯胺酮相比,右美托咪定组效果更明显。